UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023061
Receipt number R000026581
Scientific Title Continued ingestion test of the plant extract containing drink
Date of disclosure of the study information 2016/07/08
Last modified on 2016/07/25 20:35:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Continued ingestion test of the plant extract containing drink

Acronym

Continued ingestion test of the plant extract containing drink

Scientific Title

Continued ingestion test of the plant extract containing drink

Scientific Title:Acronym

Continued ingestion test of the plant extract containing drink

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the dermatological efficacy of ingesting the plant extract containing drink of healthy female

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Measurement of skin condition
(Measurement time: 0, 1 and 2 weeks after ingestion of the test drink.)

Key secondary outcomes

-Observation of skin
-Measurement of vascular function
(Measurement time: 0,1, and 2 weeks after ingestion of the test drink.)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Ingestion of active drink once a day for 14days.

Interventions/Control_2

Ingestion of placebo drink once a day
for 14days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

44 years-old >=

Gender

Female

Key inclusion criteria

-Persons who are healthy and have full time work.
-Persons who sense the stress .
-Persons who think own skin type is dry skin or combination skin.

Key exclusion criteria

-Patients with atopic dermatitis.
-Persons of skin to whom skin troubles by cosmetics happens easily.
-Persons who have severe allergic disease as pollen allergy, rhinitis, atopicdermatitis.
-Persons who have problems with electrocardiogram test such as arrhythmia.
-The person who went to hospital regularly to the medical institution within the past one month.
-Current smoker
-Persons who are pregnant or lactating, or plan to become pregnant in the near future.
-Persons who may do suntan remarkably exceeding everyday life.
-Persons to whom the person himself/herself or a family is engaged in an advertising agency, investigation and consultant business, mass media, and food, cosmetics and the health article manufacturing industry.
-Persons who plan to become participates in the other clinical studies or exam.

Target sample size

18


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kiyoshi Kataoka

Organization

Kao Corporation

Division name

R&D -Development Research- Health Beauty Products Research

Zip code


Address

2-1-3, bunka, sumida-ku, Tokyo, 131-8501, JAPAN

TEL

03-5630-9581

Email

kataoka.kiyoshi@kao.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yukinori Nakashima

Organization

Kao Corporation

Division name

R&D -Development Research- Health Beauty Products Research

Zip code


Address

2-1-3, bunka, sumida-ku, Tokyo, 131-8501, JAPAN

TEL

03-5630-9581

Homepage URL


Email

nakashima.yukinori@kao.co.jp


Sponsor or person

Institute

Kao corporation

Institute

Department

Personal name



Funding Source

Organization

Kao corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社ソフトリサーチセンター


Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 22 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 09 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 07 Day

Last modified on

2016 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026581


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name